SEC Form 3 · accession 0001683168-18-002816
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philippe Weigerstorfer
Director
Period of report
Sep 19, 2018
Accepted (ET)
Sep 21, 2018 · 4:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 22,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Issuer granted the shares of common stock as initial grant due to Mr. Weigerstorfer's appointment to the Board of Directors of the Issuer. The shares vest in three equal tranches over a period of three years with the first tranche vesting on the first anniversary of the grant date, the second tranche vesting on the second anniversary of the grant date, and the third tranche vesting on the third anniversary of the grant date.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney